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BACKGROUND and aim: Morphine co-injection has
anti-inflammatory effects on zymosan-induced peri-
tonitis in several strains of mice except that of CBA.
As peritoneal mast cells (pMCs) are much more
numerous in CBA mice than in SWISS mice, the role
of pMCs in morphine-modulated zymosan peritonitis
is compared in CBA and SWISS males.
Methods: pMCs were treated in vitro with morphine
or C48u80 for comparison of histamine release. In
vivo accumulation of leukocytes and histamine in
peritoneal exudate were recorded after intraperito-
neal injection with morphine, zymosan, or zymosan
plus morphine.
Results and conclusion: Morphine induces histamine
release by pMCs from CBA mice but not SWISS mice.
In vivo morphine-induced peritonitis is stronger in
CBA mice than SWISS mice. Corollary, morphine anti-
inflammatory effects on zymosan peritonitis are
reversed in CBA mice by its pro-inflammatory action
through CBA pMCs.
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cells, Histamine, Morphine, C48u80
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Introduction
Experimental peritonitis induced in mice by intraper-
itoneal (i.p.) zymosan injection makes it possible to
easily monitor behavioural symptoms of pain and
precisely quantify inflammation-related cells and
soluble factors in samples of peritoneal exudate.
For these reasons such a model of inflammation is
convenient for investigations of a modulatory action
of various factors on the course of inflammation,
including effects of morphine, a well-known anti-
nociceptive drug. We have previously shown that
characteristic body writhes, considered to be pain
symptoms in zymosan-injected individuals, are
completely absent in mice co-injected with mor-
phine. The low dose of morphine (5 mgukg of body
weight) attenuated pain in all the investigated strains
of mice, while only the high dose of morphine (20
mgukg of body weight) additionally inhibited the
early stages of i.p. accumulation of exudatory leuko-
cytes in most strains (C57C3H, SWISS, Balbuc,
C57BLu6)
1,2 but not CBA.
2 Anti-inflammatory effects
of morphine might be advantageous during planned
surgeries, but we should know why such effects are
not universal even among various strains of the same
species.
The main aim of the present study is to find out the
reason(s) for the insensitivity of CBA mice to anti-
inflammatory effects of the high dose of morphine.
During previous experiments on the murine perito-
nitis we recorded that the strains investigated by our
team differed in the number of peritoneal mast cells
(pMCs), which were more numerous in the order
SWISSB /OUTBREDB /C57BLB /BalbucB /CBA.
3 In the
light of the critical role of mast cells in inflammation,
4
those results prompted us to study the effects of mast
cell depletion on the subsequent zymosan-induced
peritonitis in animals with the extreme low and high
numbers of pMCs (i.e. in SWISS and CBA strains,
respectively). After a single i.p. injection of mast cell
degranulator, compound 48u80, a subsequent zymo-
san-induced peritonitis was inhibited in SWISS mice
(as previously described by Ajuebor et al.
5) but
enhanced in CBA mice. In the latter strain, C48u80-
induced mast cell degranulation was accompanied by
concomitant mast cell influx anduor local prolifera-
tion, leading to drastic inter-strain differences in the
peritoneal microenvironment at the time of zymosan
injection.
3 Therefore we put forward a hypothesis
that the inter-strain differentiation in pMC numbers
and characteristics might also be responsible for
different responses to supplementation of peritoni-
tis-inducing agent with morphine. It turned out
that, indeed, in contrast to the pMCs of SWISS mice,
the CBA pMCs are not only much more numerous,
but also very sensitive to morphine-induced hista-
mine release and the induction of inflammatory
response.
Methods
Swiss males and CBA males (6 /8 weeks old, 25 /28
g) were purchased from the Animal Department of
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365Collegium Medicum (Krako ´w, Poland). All mice were
housed four per cage in the laboratory room with
fixed light /darkness conditions (12:12 h), with water
and standard diet ad libitum. The experiments were
conducted according to license no. 16uOPu2001 from
the Local Ethical Committee.
Swiss mice and CBA mice were either untreated
(intact controls) or i.p.-injected with morphine
(M group, 20 mgukg of body weight; morphine
chloride; Polfa, Kutno, Poland), with zymosan (ZM
group, 2 mguml, 0.5 mlumice; Sigma Chemical, St
Louis, MO, USA), or zymosan supplemented with
morphine (ZM group). Animals were killed by
cervical dislocation at time 0 (controls) or after 30
min, 4 h or 8 h after i.p. injection, and their peritoneal
exudate was retrieved as described previously.
6
Following centrifugation, exudatory fluid was used
for measurement of histamine content by enzyme-
linked immunosorbent assay (ICM Pharmaceuticals,
Inc., Cost Mesa, CA, USA), while Tu ¨rk-stained exu-
datory cells were counted in a hemocytometer and
used for differential counts on MGG-stained cytospin
preparations.
Peritoneal cells from some intact animals were
prepared for an in vitro incubation of either a total
pool of PTLs
7 or purified pMCs.
8 In both instances the
cells were adjusted to approximately 70,000 pMCsuml
and incubated in tubes with various concentrations of
C48u80
8 or morphine (see later Fig. 2). After 45 min
incubation and centrifugation (10 min at 400  /g) the
cell degranulation was assessed morphologically
according to Levi-Schaffer et al.
9 on safranine-
stained
10 cytospin preparations, while the percentage
of histamine released to supernatant was assessed
and calculated according to Verbsky et al.’s
11 for-
mula:) histamine released  /(histamine released by
the inducerutotal histamine content)  /100. The re-
sults were analysed by analysis of variance and
Student’s t-test.
Results and discussion
The results of the in vivo part of the present
experiments are shown in Fig. 1. Comparison of the
modulatory effect of morphine during the initial 8 h
of zymosan-induced peritonitis in the SWISS and CBA
mice is given on the left-hand side of Fig. 1. In both
investigated strains of mice a zymosan-induced
peritoneal inflammation is connected with a massive
intraperitoneal accumulation of polymorphonuclear
leukocytes (PMNs), apparently absent before a zy-
mosan injection, with a peak 4 h after the injection. In
full concordance with our previous results, at this
time point the PMN accumulation in the ZM group of
animals was significantly inhibited in SWISS mice
1,2
while it was unaffected in CBA mice.
2 However, the
present results show additionally that in the ZM
group of SWISS mice the PMN accumulation con-
tinued thus at 8 h after the injection and was similar in
the Z and ZM groups. At that time the PMN
accumulation was already diminished in the Z group
but not the ZM group of the CBA strain of animals
(Fig. 1, left).
In attempts to find out the reasons for the
difference in the modulatory effect of morphine on
zymosan-induced peritonitis between the SWISS and
CBA mice, we compared the early events of perito-
nitis evoked in the two strains by morphine only. In
both strains an i.p. morphine injection was immedi-
ately followed by a significant influx of PMNs, which
was short-lasting in the SWISS mice while in CBA
mice it persisted for at least 4 h (Fig. 1, top right). The
number of pMCs, which was significantly higher in
the intact CBA than SWISS animals, in the former was
additionally increased by i.p. morphine injection (Fig.
1, middle right). This was accompanied by a sharp
and long-lasting increase in histamine level in the
CBA mice, while in the SWISS mice the histamine
level rose slowly. It is worth stressing that in the CBA
mice the initial level of histamine (time 0) was high,
perhaps due to mechanical manipulations during
exudate retrieval, while in the SWISS mice it was
close to zero (Fig. 1, bottom right).
Figure 2 shows the results of the in vitro part of our
experiments, when the same numbers of CBA and
SWISS-derived pMCs were incubated with either the
control mast cell degranulator, compound C48u80
8 or
morphine. The interstrain differences were already
visible in the control samples incubated in medium
only, as the percentage of spontaneous histamine
release was much higher in the CBA mice than in the
SWISS mice (57) and 21), respectively). Com-
pound C48u80 induced further histamine release
and pMC degranulation in both strains in a dose-
dependent manner (Fig. 2, right), while morphine
induced a dose-dependent histamine release from
the CBA pMCs only. No dose of morphine triggered
histamine release from the SWISS pMCs (Fig. 2, left).
The patterns of response to both agents were almost
identical in the case of the same numbers of purified
pMCs and those within the pool of peritoneal
leukocytes (PTLs) (data not shown). In both instances
the histamine release corresponded with pMC de-
granulation assessed by microscopic observations of
pMCs with ‘empty’ granules anduor those expelled
out of the cells.
The results of experiments presented here show
that the SWISS and CBA mice differ not only in the
number of pMCs, but also in the quality of these cells.
In contrast to the SWISS pMCs, which are relatively
more stable, the pMCs of the CBA strain are
susceptible to morphine-induced as well as sponta-
neous degranulation and histamine release. The mast
cells of the CBA animals are perhaps more mobile
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i.p. mast cell influx after a morphine injection in the
former strain. Comparative studies on leukocyte
mobility and on the quantity and quality of chemo-
tactic factors operating in these two strains are in
progress. So far we may conclude that morphine acts
as a strong pro-inflammatory agent in the CBA mice,
since it induces pMC degranulation and histamine
release, which result in a morphine-induced perito-
nitis much more pronounced than that evoked in the
SWISS mice by the same treatment.
Such a CBA-specific pro-inflammatory action of
morphine may at least partly explain the lack of its
anti-inflammatory action when added to an irritant
(zymosan) intraperitoneally injected in animals of this
particular strain of mice. The anti-inflammatory
effects of morphine recorded so far not only in all
the other strains of mice,
1,2 but also in fish, Atlantic
salmon
6 and goldfish,
12 seem to be connected with
the inhibition of leukocyte migration into the focus of
inflammation caused by the desensitization of their
receptors to some chemotactic factors.
13 It seems that
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FIG. 1. Comparison of early stages of peritonitis in males of CBA and SWISS mice intraperitoneally injected with zymosan (Z
group), zymosan supplemented with morphine (ZM group) or morphine only (M group). Numbers of peritoneal polymorpho-
nuclear leukocytes (PMNs), mast cells (MC) or histamine levels at time 0 (controls) or 30 min, 4 h and 8 h after injection. Data
presented as mean9 /standard error (n  /4 /6). Values with the same letter (e.g. ‘A’ and ‘A’, ‘b’ and ‘b’) do not differ signiﬁcantly
within the group, while values with different letters (e.g. ‘A’ versus ‘B’, ‘a’ versus ‘b’) vary signiﬁcantly within the group at pB /
0.05. Values signiﬁcantly different between the groups: *pB /0.05, **pB /0.01, ***pB /0.001.
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FIG. 2. In vitro effects of various doses of morphine or C48u80 on the percentage of histamine released from peritoneal mast
cells of males from CBA and SWISS mice. Data presented as mean9 /standard error (n  /4). Values sharing at least one letter
(e.g. ‘A’ and ‘AB’, ‘a’ and ‘a’, ‘d’ and ‘dc’) do not differ signiﬁcantly within the group, while values with different letters (e.g. ‘A’
versus ‘B’, ‘c’ versus ‘d’) only vary signiﬁcantly within the group at pB /0.05.
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effects are efficiently counterbalanced by morphine
pro-inflammatory effects realized mainly through the
highly morphine-sensitive mast cells of this strain.
The lack of anti-inflammatory effects of morphine
on experimental peritonitis has been recorded also in
several species of anuran amphibians (toads and
frogs). This may be due to the high levels of their
unique endogenous opioids, deltorphins and der-
morphins.
14 On the other hand, strain-specific differ-
ences in morphine effects on various components of
the murine immune system have also been recorded
by other investigators.
15 Therefore we may conclude
that the final results of morphine administration on
the immune system are dependent on the balance of
various (often contradictory) genetic, internal, and
exogenous factors.
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